News coverage about Aceto (NASDAQ:ACET) has been trending somewhat positive this week, according to Accern Sentiment. The research firm identifies positive and negative press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Aceto earned a media sentiment score of 0.15 on Accern’s scale. Accern also assigned media coverage about the company an impact score of 46.6000199272482 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
Aceto (NASDAQ ACET) opened at $10.44 on Monday. Aceto has a 12 month low of $8.29 and a 12 month high of $22.46. The firm has a market capitalization of $314.34, a P/E ratio of 8.70, a PEG ratio of 0.98 and a beta of 1.38. The company has a quick ratio of 1.46, a current ratio of 2.06 and a debt-to-equity ratio of 0.77.
Aceto (NASDAQ:ACET) last announced its earnings results on Thursday, November 2nd. The company reported $0.30 earnings per share for the quarter, topping analysts’ consensus estimates of $0.28 by $0.02. Aceto had a return on equity of 10.18% and a net margin of 1.07%. The firm had revenue of $185.26 million for the quarter, compared to the consensus estimate of $190.58 million. During the same quarter in the previous year, the business earned $0.28 EPS. The company’s revenue was up 44.7% compared to the same quarter last year. research analysts forecast that Aceto will post 1.07 earnings per share for the current fiscal year.
In other Aceto news, Chairman Albert L. Eilender sold 9,530 shares of the business’s stock in a transaction on Wednesday, September 6th. The shares were sold at an average price of $10.47, for a total transaction of $99,779.10. Following the sale, the chairman now owns 307,028 shares of the company’s stock, valued at approximately $3,214,583.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Salvatore J. Sr Guccione, Sr. sold 9,850 shares of the business’s stock in a transaction on Wednesday, September 6th. The shares were sold at an average price of $10.47, for a total transaction of $103,129.50. Following the sale, the insider now directly owns 241,262 shares in the company, valued at approximately $2,526,013.14. The disclosure for this sale can be found here. In the last quarter, insiders sold 26,283 shares of company stock worth $275,189. 4.10% of the stock is owned by company insiders.
WARNING: This story was originally posted by Community Financial News and is the property of of Community Financial News. If you are reading this story on another site, it was stolen and republished in violation of U.S. & international trademark & copyright laws. The original version of this story can be viewed at https://www.com-unik.info/2017/12/04/aceto-acet-receives-daily-coverage-optimism-rating-of-0-15.html.
Aceto Company Profile
Aceto Corporation (Aceto) is engaged in the marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products.
What are top analysts saying about Aceto Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Aceto Corporation and related companies.